Education
About Us
Working with TipRanks
Follow Us
Medtronic (MDT)
NYSE:MDT
MDT Analyst Ratings
Moderate Buy
9 Buy
9 Hold
1 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
MDT Stock 12 Month Forecast
Average Price Target
$96.00
▲(13.99% Upside)
| Highest Price Target$109.00 | Average Price Target$96.00 | Lowest Price Target$85.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Truist Financial
Reiterated
04/11/25
Robert W. Baird
Reiterated
04/10/25
Piper Sandler
Reiterated
04/04/25
Wells Fargo
Reiterated
03/31/25
Bank of America Securities
Reiterated
03/31/25
Stifel Nicolaus
Reiterated
03/31/25
TD Cowen
Reiterated
03/31/25
Bernstein
Reiterated
03/27/25
Barclays
Reiterated
03/10/25
Citi
$92→$107
Buy
27.05%
Upside
Upgraded
03/04/25
Medtronic upgraded to Buy from Neutral at CitiMedtronic upgraded to Buy from Neutral at Citi
RBC Capital
$105
Buy
24.67%
Upside
Reiterated
02/27/25
Analysts Offer Insights on Healthcare Companies: MoonLake Immunotherapeutics (NASDAQ: MLTX), MannKind (NASDAQ: MNKD) and Medtronic (NYSE: MDT)
Mizuho Securities
$100
Buy
18.74%
Upside
Reiterated
02/19/25
We expect gross margin dynamics such as FX and impact from revenue rebound to be focuses on the Investor call. Guidance: FY:25 outlook unchanged to at top and bottom lines. Despite the slight top-line weakness, both FY'25 organic revenue growth guidance of 4.75%-5.0% and EPS guidance of $5.44-5.50 from the prior quarter were reiterated and unchanged with the F2Q results. The reported guidance bakes in -10bps of incremental FX pressure with the revised range going to +3.4%-3.8% (prior +3.4%-3.9% prior). Consistency at the top-line through FYE and strength at the margin should offset increased FX pressures which keeps the adjusted EPS unchanged at $5.44-$5.50 (versus $5.45 Street forecast). Given proximity to the April fiscal year-end, we expect only marginal commentary on the direction for the early FY:26 outlook on the 8amEST call.
UBS
$85→$95
Hold
12.80%
Upside
Reiterated
02/19/25
Medtronic, Inc. (MDT) PT Raised to $95 at UBSUBS analyst Danielle Antalffy raised the price target on Medtronic, Inc. (NYSE: MDT) to $95.00 (from $85.00) while maintaining a Neutral rating.
Goldman Sachs
$83→$85
Sell
0.93%
Upside
Reiterated
02/19/25
Medtronic price target raised to $85 from $83 at Goldman SachsMedtronic price target raised to $85 from $83 at Goldman Sachs
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Truist Financial
Reiterated
04/11/25
Robert W. Baird
Reiterated
04/10/25
Piper Sandler
Reiterated
04/04/25
Wells Fargo
Reiterated
03/31/25
Bank of America Securities
Reiterated
03/31/25
Stifel Nicolaus
Reiterated
03/31/25
TD Cowen
Reiterated
03/31/25
Bernstein
Reiterated
03/27/25
Barclays
Reiterated
03/10/25
Citi
$92→$107
Buy
27.05%
Upside
Upgraded
03/04/25
Medtronic upgraded to Buy from Neutral at CitiMedtronic upgraded to Buy from Neutral at Citi
RBC Capital
$105
Buy
24.67%
Upside
Reiterated
02/27/25
Analysts Offer Insights on Healthcare Companies: MoonLake Immunotherapeutics (NASDAQ: MLTX), MannKind (NASDAQ: MNKD) and Medtronic (NYSE: MDT)
Mizuho Securities
$100
Buy
18.74%
Upside
Reiterated
02/19/25
We expect gross margin dynamics such as FX and impact from revenue rebound to be focuses on the Investor call. Guidance: FY:25 outlook unchanged to at top and bottom lines. Despite the slight top-line weakness, both FY'25 organic revenue growth guidance of 4.75%-5.0% and EPS guidance of $5.44-5.50 from the prior quarter were reiterated and unchanged with the F2Q results. The reported guidance bakes in -10bps of incremental FX pressure with the revised range going to +3.4%-3.8% (prior +3.4%-3.9% prior). Consistency at the top-line through FYE and strength at the margin should offset increased FX pressures which keeps the adjusted EPS unchanged at $5.44-$5.50 (versus $5.45 Street forecast). Given proximity to the April fiscal year-end, we expect only marginal commentary on the direction for the early FY:26 outlook on the 8amEST call.
UBS
$85→$95
Hold
12.80%
Upside
Reiterated
02/19/25
Medtronic, Inc. (MDT) PT Raised to $95 at UBSUBS analyst Danielle Antalffy raised the price target on Medtronic, Inc. (NYSE: MDT) to $95.00 (from $85.00) while maintaining a Neutral rating.
Goldman Sachs
$83→$85
Sell
0.93%
Upside
Reiterated
02/19/25
Medtronic price target raised to $85 from $83 at Goldman SachsMedtronic price target raised to $85 from $83 at Goldman Sachs
Best Analysts Covering Medtronic
Which Analyst Should I Follow If I Want to Buy MDT and Sell After:
1 Month
xxx
Success Rate
10/19 ratings generated profit
Average Return
+1.22%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 52.63% of your transactions generating a profit, with an average return of +1.22% per trade.
3 Months
xxx
Success Rate
13/19 ratings generated profit
Average Return
+3.25%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 68.42% of your transactions generating a profit, with an average return of +3.25% per trade.
1 Year
Success Rate
19/29 ratings generated profit
Average Return
+3.42%
reiterated a buy rating 16 days ago
Copying Josh Jennings's trades and holding each position for 1 Year would result in 65.52% of your transactions generating a profit, with an average return of +3.42% per trade.
2 Years
xxx
Success Rate
13/19 ratings generated profit
Average Return
+0.55%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 68.42% of your transactions generating a profit, with an average return of +0.55% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
MDT Analyst Recommendation Trends
Rating
Dec 24
Jan 25
Feb 25
Mar 25
Apr 25
Strong Buy
0
0
0
0
0
Buy
26
23
21
21
17
Hold
15
12
16
18
17
Sell
0
0
1
1
1
Strong Sell
0
0
0
0
0
total
41
35
38
40
35
Each month's total comprises the sum of three months' worth of ratings.
MDT Financial Forecast
MDT Stock Forecast FAQ
What is MDT’s average 12-month price target, according to analysts?
Based on analyst ratings, Medtronic’s 12-month average price target is $96.00.
What is MDT’s upside potential, based on the analysts’ average price target?
Medtronic has 13.99% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is MDT a Buy, Sell or Hold?
Medtronic has a consensus rating of Moderate Buy which is based on 9 buy ratings, 9 hold ratings and 1 sell ratings.
What is Medtronic’s price target?
The average price target for Medtronic is $96.00. This is based on 19 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $109.00 ,the lowest forecast is $85.00. The average price target represents 13.99% Increase from the current price of $84.22.
The highest analyst price target is $109.00 ,the lowest forecast is $85.00. The average price target represents 13.99% Increase from the current price of $84.22.
What do analysts say about Medtronic?
Medtronic’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 19 Wall Streets Analysts.
How can I buy shares of MDT?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.